Low-dose Glucocorticoid Vasculitis Induction Study
Low-dose Glucocorticoids Plus Rituximab Versus High-dose Glucocorticoids Plus Rituximab for Remission Induction in ANCA-associated Vasculitis; a Multicentre, Open Label, Randomised Control Trial
Sponsor: Chiba University
A PHASE4 clinical study on Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis and Microscopic Polyangiitis, this trial is ongoing. The trial is conducted by Chiba University and has accumulated 11 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Feb 2023 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
-
Feb 2021 — Feb 2023 [monthly]
Active Not Recruiting PHASE4
▶ Show 6 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE4
-
Feb 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Feb 2019 — Feb 2020 [monthly]
Recruiting PHASE4
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE4
-
Feb 2018 — Jun 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2018 [monthly]
Recruiting PHASE4
First recorded
Oct 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chiba University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Akita, Japan, Asahi, Japan, Chiba, Japan, Fukushima, Japan, Kamogawa, Japan, Kawagoe, Japan, Matsudo, Japan, Mibu, Japan, Narita, Japan, Niigata, Japan and 5 more location s